Author Correction: Targeting the DYRK1A kinase prevents cancer progression and metastasis and promotes cancer cells response to G1/S targeting chemotherapy drugs

Authors and Affiliations

1. Department of Medicine, Cancer Research Program, McGill University Health Center, Montreal, Quebec, H4A 3J1, Canada

   Amina Jamal Laham, Ni Wang, Gang Yan, Julien Boudreault, Suhad Ali & Jean-Jacques Lebrun

2. College of Medicine, University of Sharjah, Sharjah, 27272, United Arab Emirates

   Amina Jamal Laham & Maha Saber-Ayad

3. Research Institute for Medical and Health Sciences, University of Sharjah, Sharjah, 27272, United Arab Emirates

   Amina Jamal Laham, Raafat El-Awady & Maha Saber-Ayad

4. College of Pharmacy, University of Sharjah, Sharjah, 27272, United Arab Emirates

   Raafat El-Awady

Corresponding authors

Correspondence to Raafat El-Awady or Jean-Jacques Lebrun.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions